Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Paris
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

ALCAR:FP

67.5300 EUR 0.9600 1.40%

As of 12:35:00 ET on 03/27/2015.

Snapshot for Carmat (ALCAR)

Open: 68.0500 Day's Range: 66.0500 - 68.4500 Volume: 6,678
Previous Close: 68.4900 52wk Range: 61.2200 - 96.0000 1-Yr Rtn: -22.18%

Stock Chart for ALCAR

No chart data available.
  • ALCAR:FP 67.5300
  • 1D
  • 1M
  • 1Y
68.4900
Interactive ALCAR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALCAR

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -4.2670
Est. EPS (EUR) (12/2015) -4.1770
Est. PEG Ratio -
Market Cap (M EUR) 289.26
Shares Outstanding (M) 4.28
30 Day Average Volume 4,574
Price/Book (mrq) 59.9890
Price/Sale (ttm) 102.2506
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/21/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALCAR

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ALCAR

Carmat is medical technology start-up company. The Company intends to market a fully implantable artificial heart for patients suffering in the aftermath of a heart attack or with late-stage heart failure and for whom standard drug therapy, ventricular assistance and/or a heart transplant have failed or are not possible.

Marcello ConvitiChief Executive OfficerPatrick CoulombierChief Operating Officer
Herve BocquetDir:IndustrialEric RichezDir:Business Development
More Company Profile & Key Executives for ALCAR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil